Comparing left and right heart pacing after atrioventricular node ablation for atrial fibrillation
Official title: Benefit of Permanent Stimulation of the Left Branch of the His Bundle Versus Right Ventricular Stimulation After Atrioventricular Node Ablation for Rapid Atrial Fibrillation
Run by University Hospital, Rouen · NCT06061978 · Data updated 2026-11-12
This study is testing whether pacing the heart from the left side works better than the traditional right side for people who have had a procedure to treat rapid atrial fibrillation.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | University Hospital, Rouen Academic / other |
| Locations | 1 site (Caen) |
| Status | Recruiting |
| Started | November 27, 2023 |
| Main results expected | May 27, 2027 |
| Study ends | May 27, 2027 |
| Registry record updated | February 10, 2026 |
| Trial ID | NCT06061978 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients with a pacemaker implanted who have recently undergone atrioventricular node ablation for rapid atrial fibrillation.
✕Probably not a fit
Patients with significant heart function impairment (LVEF < 40%) or those unable to perform a maximal cardiorespiratory effort test may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the functional benefits of pacing from the left bundle branch of His compared to traditional right ventricular pacing in patients who have undergone atrioventricular node ablation for rapid atrial fibrillation. Participants will have a pacemaker implanted with leads in both locations, and the study aims to determine which pacing method provides better outcomes. The study will include patients who have had the ablation procedure within the last 15 days and meet specific inclusion criteria. The goal is to assess the effectiveness of these pacing strategies in improving heart function and patient quality of life.
Why it matters
Potential benefit: If successful, this study could lead to improved heart function and quality of life for patients with rapid atrial fibrillation.
How similar studies have gone: While the specific approach of left bundle branch pacing is relatively novel, similar studies have shown promising results in improving outcomes for patients with pacing needs.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1/ Pacemaker implanted patient with LBTP lead and back-up right ventricular lead who subsequently underwent successful atrioventricular node ablation for rapid AF 2) NAV ablation procedure performed less than 15 days ago 3) Age ≥ 18 years 4) Woman of childbearing age with effective contraception (estrogen-progestin or intrauterine device or tubal ligation) for at least 1 month and for the duration of the study, and a negative urine pregnancy test by B-HCG at inclusion Or, Postmenopausal woman: confirmatory diagnosis (non-medically induced amenorrhea for at least 12 months prior to the inclusion visit). 5\) Membership of a social security scheme 6) Patient follow-up feasible 7) Patient has read and understood the information leaflet and signed the informed consent form Exclusion Criteria: 1. Impairment of autonomy such that a maximal cardiorespiratory effort test (VO2 Max test) cannot be performed under good conditions (ADL scale \< 5). 2. LVEF \< 40% at inclusion 3. Person deprived of liberty by an administrative or judicial decision, or person under court protection, sub-guardianship or curatorship. 4. Patient participating in another interventional trial 5. Any history of illness or psychological or sensory abnormality likely to prevent the subject from fully understanding the conditions required for participation in the protocol, or from giving informed consent. 6. Pregnant, parturient or breast-feeding women, or those without proven contraception
Where it's running
-
CHU de CAEN
Caen, France Recruiting
Study contacts
- Principal investigator: Corentin CHAUMONT, MD — University Hospital, Rouen
- Study coordinator: Corentin CHAUMONT, MD
- Email: corentin.chaumont@chu-rouen.fr
- Phone: 232888116
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Hospital-level care delivered at home for acutely ill adults
This trial tries to deliver hospital-level care at home to adults with sudden illnesses like infections, heart failure, COPD, asthma, or gout flares to see if it's as safe, improves patient experience, and lowers costs.
-
See if preoperative anxiety affects recovery after major digestive cancer surgery
This study tests whether anxiety before surgery is linked to more complications after major digestive cancer operations in French-speaking adults.
-
Using EEG to monitor sleep quality in ICU patients with respiratory failure
We will test whether continuous EEG monitoring can better track sleep quality than nurse observations in conscious adults hospitalized in the ICU for acute respiratory failure.
-
Gynecological and sexual aftereffects following rectal cancer treatment
This work will test whether gynecological anatomical changes after rectal cancer treatment are linked to ongoing sexual problems in women aged 18–60 who are in remission.
-
Long-read genetic analysis for Spinal Muscular Atrophy (LOREASI)
This project tries a long-read DNA technique on adults with known SMN1 copy-number patterns to find hidden '2+0' carrier genotypes that standard tests miss.
-
Carotid artery wall viscosity and memory problems in older adults
This project will test whether the viscous behavior of the carotid artery wall is linked to memory problems in people over 70 with memory complaints, Alzheimer's disease, or vascular dementia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.